KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Gross Profit (2016 - 2025)

Historic Gross Profit for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $6.3 billion.

  • Abbott Laboratories' Gross Profit rose 601.31% to $6.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $24.5 billion, marking a year-over-year increase of 701.84%. This contributed to the annual value of $23.2 billion for FY2024, which is 501.49% up from last year.
  • Per Abbott Laboratories' latest filing, its Gross Profit stood at $6.3 billion for Q3 2025, which was up 601.31% from $6.3 billion recorded in Q2 2025.
  • Abbott Laboratories' 5-year Gross Profit high stood at $6.9 billion for Q1 2022, and its period low was $5.3 billion during Q2 2021.
  • Its 5-year average for Gross Profit is $5.9 billion, with a median of $5.9 billion in 2025.
  • In the last 5 years, Abbott Laboratories' Gross Profit soared by 3622.05% in 2021 and then plummeted by 2159.81% in 2023.
  • Quarter analysis of 5 years shows Abbott Laboratories' Gross Profit stood at $6.7 billion in 2021, then decreased by 17.96% to $5.5 billion in 2022, then increased by 3.4% to $5.7 billion in 2023, then rose by 6.1% to $6.0 billion in 2024, then increased by 4.34% to $6.3 billion in 2025.
  • Its last three reported values are $6.3 billion in Q3 2025, $6.3 billion for Q2 2025, and $5.9 billion during Q1 2025.